Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Jochen Gohlke und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States. Hauptthemen laut MEDLINE: Connectin, Muscle, Skeletal, Muscular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Pathogenic variants in the titin gene (TTN) are known to cause a wide range of cardiac and musculoskeletal disorders, with skeletal myopathy mostly attributed to biallelic variants. We identified monoallelic truncating variants (TTNtv), splice site or internal deletions in TTN in probands with mild, progressive axial and proximal weakness, with dilated cardiomyopathy frequently developing with age. These variants segregated in an autosomal dominant pattern in 7 out of 8 studied families. We investigated the impact of these variants on mRNA, protein levels, and skeletal muscle structure and function. Results reveal that nonsense-mediated decay likely prevents accumulation of harmful truncated protein in skeletal muscle in patients with TTNtvs. Splice variants and an out-of-frame deletion induce aberrant exon skipping, while an in-frame deletion produces shortened titin with intact N- and C-termini, resulting in disrupted sarcomeric structure. All variant types were associated with genome-wide changes in splicing patterns, which represent a hallmark of disease progression. Lastly, RNA-seq studies revealed that GDF11, a member of the TGF-β superfamily, is upregulated in diseased tissue, indicating that it might be a useful therapeutic target in skeletal muscle titinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States.
- Department of Neurology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, Columbus, OH 43210, United States.
- Research, Innovation and Impact Core Facilities Department, University of Arizona, 1333 N. Martin Ave, Tucson, AZ 85719, United States.
- Invitae Corporation, 1400 16th St., San Francisco, CA 94103, United States.
- Department of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, 370 W 9th Ave, Columbus, OH 43210, United States.
ORCID-Profile: Jennifer Roggenbuck
Förderung
- NIAMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Gohlke, J., Lindqvist, J., Hourani, Z., Heintzman, S., Tonino, P., Elsheikh, B., Morales, A., Vatta, M., Burghes, A., Granzier, H., & Roggenbuck, J. (2024). Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae136
Vancouver
Gohlke J, Lindqvist J, Hourani Z, Heintzman S, Tonino P, Elsheikh B, et al. Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae136
BibTeX
@article{Gohlke2024,
author = {Gohlke, Jochen and Lindqvist, Johan and Hourani, Zaynab and Heintzman, Sarah and Tonino, Paola and Elsheikh, Bakri and Morales, Ana and Vatta, Matteo and Burghes, Arthur and Granzier, Henk and Roggenbuck, Jennifer},
title = {Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae136}
}
EUVIMED